ABC008

· Abcuro, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABC008, covering 2024-10-28 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis [Phase 2, Phase 3]